Is there a place for cyclophosphamide in the treatment of giant-cell arteritis? A case series and systematic review

Cyclophosphamide is an interesting option for GCA patients with GC-dependent disease or with severe GC-related side effects, especially when conventional immunosuppressive agents have failed.